NovaBridge Biosciences
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 0VY.F | ACTI.ST | CHRS | BBOT | CRDF | CMPX | |
|---|---|---|---|---|---|---|
| Market cap | 101.50M | 102.54M | 131.36M | 184.40M | 67.60M | 137.35M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -0.6 | — | -1.3 | -0.8 | -1.6 | -1.4 |
| Price/book | 0.6 | 2.8 | 2.2 | 0.6 | 2.2 | 0.8 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −75.14% | −42.74% | −42.95% | −81.22% | −61.33% | −80.29% |
| Today | −1.69% | +5.71% | +5.54% | −0.86% | +0.67% | +1.29% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All 0VY.F news ›NovaBridge Biosciences (NBP) Discusses Mature Givastomig Data and Registrational Development Strategy Transcript
NovaBridge Biosciences (NBP) Discusses Mature Givastomig Data and Registrational Development Strategy November 2, 2026 8:00 AM EST Srishti Gupta - CEO & DirectorPhillip Dennis - Chief Medical Officer Samuel KlempnerDaina Graybosch -…
NovaBridge Biosciences Appoints Chuck Silberstein as Chief Financial Officer
ROCKVILLE, Md., Oct. 28, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences, Inc. (“NovaBridge” or the “Company”) (NASDAQ: NBP) today announced the appointment of Chuck Silberstein, M.D., M.B.A. as Chief Financial Officer, effective November…
More from 1 other outlet
NovaBridge Biosciences Announces Expanded Givastomig Safety and Efficacy Data to be Presented at the European Society for Medical Oncology 2026
ROCKVILLE, Md., Oct. 08, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (NASDAQ: NBP) today announced that updated results from the Phase 1b co... NovaBridge Biosciences Announces Expanded Givastomig Safety and Efficacy Data to be…
Novabridge Biosciences Signals Promise Amid Funding Hurdles
Novabridge Biosciences ((NBP)) has held its Q2 earnings call. Read on for the main highlights of the call. Novabridge Biosciences’ latest earnings call struck a tone of cautious optimism, with management highlighting strong clinical…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- seekingalpha.com2
- markets.businessinsider.com1
- stocktitan.net1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 4 articles, not a forecast.